echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Nat Metab Xiong Wei's team reveals the neural mechanisms by which alcohol-cannabis synergy leads to motor disorders

    Nat Metab Xiong Wei's team reveals the neural mechanisms by which alcohol-cannabis synergy leads to motor disorders

    • Last Update: 2022-10-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Editor-in-Charge | Alcohol and tetrahydrocannabinol Δ9-tetrahydrocannabinol (THC) are two common psychoactive substances that can severely affect brain function (e.
    g.
    , brain cognition, blood-brain barrier permeability, and motor coordination function)
    with acute or chronic use.

    Notably, numerous clinical and fundamental studies have shown that a combination of alcohol and cannabis can cause more serious motor coordination disorders
    than either alone.

    The National Highway Traffic Safety Administration issued a dedicated statement highlighting that the mixed use of alcohol and marijuana will cause more vicious traffic accidents
    .

    Although the combined use of cannabis and alcohol can cause toxicity reinforcement and bring more serious social burdens, the neural mechanism of this synergistic reinforcement has not been clear
    until now 。 On September 15, 2022, Professor Xiong Wei's research group of the Department of Life Sciences and Medicine of the University of Science and Technology of China published a research paper entitled Combined alcohol and cannabinoid exposure leads to synergistic toxicity by affecting cerebellar Purkinje cells online in the journal Nature Metabolism

    The study revealed the neural mechanism by which alcohol and cannabinoids target the presynaptic cannabinoid receptor (CB1R) and extrasynaptic glycine receptor (esGlyR) in the cerebellar Purkinye cells synergistically lead to dyskinesia, and propose the development of novel drugs targeting esGlyR for the relief of this dyskinesia, further accelerating the clinical treatment
    of alcohol and cannabis abuse 。 Professor Xiong Wei's research group of the University of Science and Technology of China has long been engaged in the study of the molecular and loop mechanisms of inhibitory ion channel GlyR regulating neurological diseases, and comprehensively studied the mechanism of cannabinoid-targeted GlyR regulation of various neurological diseases by comprehensively using multidisciplinary research methods such as ex vivo and in vivo electrophysiological patch forceps, bioinformatics drug screening, nerve loop tracing and mass spectrometry analysis
    .

    Up to now, he has made a series of important research achievements in the pathogenesis, treatment and research and development of new drugs in chronic pain, familial convulsions, epilepsy, movement disorders and other neurological diseases (Nat Chem Biol, 2011; J Exp Med, 2012; Nat Neurosci, 2014; Neuropharmacology, 2018; iScience, 2019; JBC, 2020; FASEB J, 2020; Cell Reports, 2020), revealing a novel mechanism
    by which cannabinoids treat various neurological disorders by targeting GlyR.


    In the latest Nature Metabolism paper, researchers demonstrated in mouse models that both low and high doses of alcohol in combination with THC can cause more severe dyskinesia than either alone
    .

    After the evaluation of motor coordination behavior, the researchers found through c-fos nucleus screening that Pukenye cells in the 4/5Cb cerebral region are significantly activated
    during the process of alcohol and cannabinoids synergistically leading to dyskinesic behavior.

    Subsequently, after in-brain microinjection and electrophysiological record analysis, the researchers found that CB1R distributed before the synapse of Pukenye's cells and esGlyR outside the synapse were key targets
    for the synergistic effect of alcohol and cannabinoids 。 In addition, the researchers used newly synthesized cannabinoid fluorescent probes, small animal imaging, and mass spectrometry analysis to find that alcohol can significantly speed up the speed of THC through the blood-brain barrier, suggesting that even low-dose alcohol can improve the permeability of the blood-brain barrier in a very short period of time, accelerate THC through the blood-brain barrier into the brain, and enhance the synergy between
    alcohol and cannabinoids in the brain.

    Finally, by chemically modifying THC, the researchers developed a novel cannabinoid compound, DDT, which can specifically block THC's regulatory effect on esGlyR and can greatly alleviate the dyskinesia caused by the synergy of alcohol and cannabinoids
    .
    Zou Guichang, a special associate researcher at the University of Science and Technology of China, and Xia Jing, a doctoral candidate, are the co-first authors of the paper, and Professor Xiong Wei is the sole corresponding author of
    the paper.


    Illustration: Schematic diagram of alcohol and cannabinoids synergistically causing dyskinesia


    Original link:

    Maker: Eleven

    Reprint Notice

    【Non-original article】The copyright of this article belongs to the author of the article, welcome individuals to forward and share, without the author's permission is prohibited from reprinting, the author has all legal rights, violators will be prosecuted
    .



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.